HSANZ Presidential Symposium
Tracks
HSANZ
| Monday, October 19, 2026 |
| 10:30 AM - 12:00 PM |
Speaker
Prof Daniel Thomas
Consultant Haematologist
Adelaide University
Durable efficacy of lenzilumab plus azacitidine in newly diagnosed proliferative CMML patients: Interim analysis after four years of study commencement
10:30 AM - 10:45 AM
Ms Alia Cibich
Bmt Data Manager
Royal Adelaide Hospital
Clonal architecture and microenvironmental drivers of donor-derived haematological neoplasm after allogeneic haematopoietic stem cell transplant
10:45 AM - 11:00 AM
Dr Criselle D'Souza
Postdoctoral Researcher
Peter MacCallum Cancer Centre
Development of an allogeneic CAR-T cell therapy for mature T cell Lymphomas
11:00 AM - 11:15 AM
Assoc Prof Maggie Kalev
Associate Professor
University of Auckland
Matrix stiffness drives dysfunctional megakaryopoiesis in a novel human 3D model of primary myelofibrosis
11:15 AM - 11:30 AM
Dr Jeremy Hu
Haematology Registrar
Northern Health
Real-world application of the IMS/IMWG consensus genomic staging criteria for high-risk multiple myeloma: a report from the Australia and New Zealand Myeloma and Related Diseases Registry
11:30 AM - 11:45 AM
Dr Joanne Tan
Consultant Haematologist
Alfred Health
A cytokine-based biomarker model to predict the onset of moderate to severe chronic graft-versus-host disease
11:45 AM - 12:00 PM
